LQDA
NASDAQLiquidia Corporation
Price$75.48-0.59 (-0.78%)
01:30 PM07:45 PM
News · 26 weeks123+29%
2025-12-282026-06-21
Mix7990d
- Insider43(54%)
- SEC Filings28(35%)
- Other6(8%)
- Earnings1(1%)
- Leadership1(1%)
Latest news
25 items- INSIDERDirector Johnson David Edward was granted 5,882 shares (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Singh Raman was granted 5,882 shares, increasing direct ownership by 15% to 44,637 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Bloch Stephen M was granted 5,882 shares, increasing direct ownership by 9% to 71,594 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Degoa Damian was granted 5,882 shares, increasing direct ownership by 7% to 92,353 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Horobin Joanna was granted 5,882 shares, increasing direct ownership by 17% to 39,637 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Kirsch Arthur S was granted 5,882 shares, increasing direct ownership by 14% to 46,637 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Rielly-Gauvin Katherine was granted 5,882 shares, increasing direct ownership by 15% to 44,637 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Manning Paul B was granted 5,882 shares, increasing direct ownership by 1% to 475,465 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- SECLiquidia Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Liquidia Corp (0001819576) (Filer)
- INSIDERDirector Bloch Stephen M sold $14,012,580 worth of shares (196,111 units at $71.45) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Human Resource Officer Krepp Sarah sold $1,748,527 worth of shares (24,880 units at $70.28) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 121,863 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Bloch Stephen M sold $26,634,789 worth of shares (388,223 units at $68.61) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- PRLiquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific SessionsMORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that the company will present four posters at the PHA 2026 International PH Conference and Scientific Sessions taking place June 11-14 in Dallas. Liquidia will present data from Cohort A of its ASCENT study of YUTREPIA® (treprostinil) inhalation powder, including patient-reported cough outcomes in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) over 24 weeks of treatment. The company will also present
- SECSEC Form 144 filed by Liquidia Corporation144 - Liquidia Corp (0001819576) (Subject)
- INSIDERChief Development Officer Khindri Sanjeev sold $270,612 worth of shares (4,134 units at $65.46) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 67,132 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Bloch Stephen M sold $14,273,683 worth of shares (220,835 units at $64.64) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Manning Paul B sold $12,782,059 worth of shares (200,000 units at $63.91) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Bloch Stephen M sold $5,507,782 worth of shares (84,800 units at $64.95) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- SECLiquidia Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Liquidia Corp (0001819576) (Filer)
- SECSEC Form 144 filed by Liquidia Corporation144 - Liquidia Corp (0001819576) (Subject)
- PRLiquidia Corporation Announces Inclusion in the S&P SmallCap 600® IndexMORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will be added to the S&P SmallCap 600® Index, effective prior to the opening of trading on June 22, 2026. Introduced in 1994, the S&P SmallCap 600 is a widely followed benchmark of 600 U.S. small-cap companies selected by S&P Dow Jones Indices based on market capitalization, liquidity, shares available for public trading, and profitability criteria. Dr. Roger Jeffs, Liquidia's Chief Executive Officer, said: "Inclusion in the S&P Sm
- PRMarvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from S&P MidCap 400 and S&P SmallCap 600 are no longer representative of the mid-cap and small-cap market space, respectively. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name ActionCompany NameTickerGICS SectorJune 22, 2026
- SECSEC Form 144 filed by Liquidia Corporation144 - Liquidia Corp (0001819576) (Subject)
- SECSEC Form 144 filed by Liquidia Corporation144 - Liquidia Corp (0001819576) (Subject)
- INSIDERChief Human Resource Officer Krepp Sarah sold $16,800 worth of shares (276 units at $60.87) as part of a pre-agreed trading plan, decreasing direct ownership by 0.19% to 146,743 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
LQDA FAQ
7 questionsWhat does Liquidia Corporation do?
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Where does LQDA stock trade?
Liquidia Corporation (LQDA) is listed on NASDAQ.What sector and industry is LQDA in?
Liquidia Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Liquidia Corporation go public?
Liquidia Corporation (LQDA) completed its IPO in 2018.What are analysts saying about LQDA?
Liquidia Corporation has had 8 recent analyst actions on file. The most recent action was from Wells Fargo: Overweight with a $3100.00 price target on 2025-10-20. Recent price targets range from $1300.00 to $4300.00.What companies are similar to LQDA?
Notable peers in the same industry include UTHR (United Therapeutics Corporation), TVTX (Travere Therapeutics Inc.), VCYT (Veracyte Inc.). Compare LQDA side-by-side with any of them on Quantisnow.How can I track LQDA on Quantisnow?
Quantisnow aggregates Liquidia Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LQDA to receive live email and push alerts on every new disclosure.